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I would like to thank Dr. Rosenberg and the ASHG
Awards Committee for this exceptional honor. It is a
particular privilege to receive this award from Dr. Ro-
senberg, who played such a significant role in my career
development by recruiting me to Yale 20 years ago.
When Lee first contacted me regarding the Curt Stern
Award, he told me that the best part of being chair of
the Awards Committee is being able to inform the award
recipients. Well, as he found out, informing me turned
out to be no modest task. His first mistake was trying
to contact me by e-mail. Many of you know the chal-
lenge of trying to reach me by e-mail. But he was per-
sistent and followed up with phone calls. I did call back,
but inevitably after he had left the office (he has normal
office hours; I do not). Eventually, we did make contact,
and the call was predictably celebratory.
Receiving an honor such as this provides an oppor-
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tunity to reminisce and examine not only the past decade
(for which the Stern Award is designated) but also pre-
vious decades of research in human genetics and in my
particular area, genetic epidemiology, as well. I am par-
ticularly aware of the fact that I am not a bench scientist
but a population and statistical researcher, which makes
the decision of the Awards Committee that much more
meaningful to me, in recognizing the contributions that
statistical types make and have made to the field of hu-
man genetics.
In tracing my own personal history and development
in this field and to gain some perspective, it was useful
to examine the parallel developments going on in human
genetics, genetic epidemiology, and statistical genetics.
In doing so, I also came to appreciate that both delib-
erate as well as random events shape one’s career and
that both are important. Perhaps an analogy is provided
in the population-genetics concepts of natural selection
and genetic drift, both of which contribute to the mold-
ing of gene frequencies in a population over time.
In table 1, I have outlined my own personal career
course in parallel with concurrent events in human ge-
netics and genetic epidemiology. I have started with my
graduate-school training, since, up to that point, I was
a pure mathematician. Having discovered the field of
biomathematics and a newly kindled interest in biology,
I was fortunate to find the recently established graduate
program in biomathematics at UCLA. In my second
quarter in that program, I enrolled in a course in human
genetics taught by Anne Spence and John Merriam. After
a few weeks, I knew I had found my discipline. I was
fascinated not only by the natural logic of genetics and
its relevance for human development but also by the
mathematical elegance underlying its principles. I also
soon learned that, not surprisingly, many of the early
developments in the field of statistics derived from
problems arising in genetics. I was also lucky to have
selected a graduate program whose faculty included two
leading statistical geneticists, Ken Lange and Anne
Spence, who became my graduate advisers. While at
UCLA, I also was fortunate to have exposure to the field
of population genetics through course work taught by
Ayesha Gill in the Biology Department. It became an-
other passion of mine, although it would be years before
I was able to act upon it.
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Table 1
A Personal History
Dates Location Field
1973–1979 Graduate school, UCLA, Department of Biomathematics.
Advisers: Ken Lange, Anne Spence, and Ayesha Gill
Family, twin, and adoption studies; path analysis, segregation anal-
ysis, and pedigree analysis; Morton-Elston debate over major-
gene evidence
1979–1984 Columbia University, Department of Psychiatry, School
of Medicine, and Department of Biostatistics, School
of Public Health. Advisers: Zena Stein and Mervyn
Susser (Epidemiology)
Linkage analysis in pedigrees (Elston and Stewart [1971] algorithm,
LIPED computer program [Ott 1974]); RFLPs
1984–1994 Yale University, Department of Epidemiology and Public
Health (Biostatistics) and Department of Human
Genetics
Linkage analysis in pedigrees continues; microsatellites, positional
cloning, Human Genome Project inception; linkage analysis of
complex traits (small families and sib pairs)
1995–2004 Stanford University, Department of Genetics, Department
of Statistics, and Department of Health Research and
Policy
Resequencing of the human genome; SNPs; association studies;
linkage disequilibrium; HapMap; population genetics and epide-
miology; admixture mapping
In the mid-1970s, the field of genetic epidemiology
focused primarily on the estimation of heritability of
traits via family, twin, and adoption studies; path analy-
sis; and inferences regarding the role of major genes in
the familial aggregation of traits through segregation
analysis. Complex models for segregation analysis—in-
cluding major-gene and polygenic components and para-
metric transmission parameters—evolved, along with in-
tense debates about the sensitivity and specificity of
methods focusing on nuclear families that allowed for
genetic alternatives to major-gene inheritance (i.e., poly-
genic inheritance, as promoted by Newton Morton and
colleagues) versus extended family pedigrees that did not
allow alternative genetic models but did allow for trans-
mission patterns to be non-Mendelian (promoted by
Robert Elston and his colleagues). Analysis of extended
pedigrees was made possible by Elston and Stewart’s
recursive algorithm (Elston and Stewart 1971). Their
seminal paper also showed how to efficiently calculate
LOD scores for linkage analysis in extended pedigrees,
perhaps its most far-reaching impact. Soon afterward,
Jurg Ott developed the program LIPED (Ott 1974),
which served as a mainstay for performing parametric
linkage analysis for nearly a decade.
Upon my move to my first position at Columbia in
1979, I was well trained in a variety of disciplines, in-
cluding mathematics, statistics and biostatistics, bio-
mathematics, biology, and genetics. The rigors of the
Ph.D. program at UCLA also required a year of medical-
school course work. Thus, I felt I was well prepared to
take on the role of statistical geneticist, applying math-
ematical models to the analysis of genetic and family
data to better understand the inheritance of human dis-
eases and traits. Although segregation analysis was still
flourishing, linkage analysis was becoming more prom-
inent because of the availability of computer programs
for performing the complex calculations that previously
were cumbersome. However, running programs such as
LIPED in those days was still not without challenge,
since computers had not yet evolved to the point that
data input was electronic. The program and the pedigree
information needed to be read from hundreds of com-
puter cards, which were often dropped, torn, or mangled
in the card readers. How things have changed!
The greatest limitation to linkage analysis in those
days, however, was the paucity of genetic markers that
could be employed, since they were phenotypically based
on blood groups and serum proteins. Thus, the most
significant developments influencing the course of hu-
man genetics were the recognitions that the DNA itself
could serve as the basis for genetic markers (Kan and
Dozy 1978) and that restriction-fragment–length poly-
morphisms that spanned the entire human genome could
be derived and used for linkage analysis (Botstein et al.
1980). The early identification of the location of the gene
for Huntington disease on chromosome 4 (Gusella et al.
1983) demonstrated that linkage analysis in humans was
no longer an arcane, low-yield dalliance but rather the
first step in a realistic effort to identify mutations un-
derlying human genetic disease. At this point, there was
also the recognition that simultaneous analysis of ad-
jacent markers could provide greater precision in locat-
ing disease genes, and statistical methods and software
for generating multilocus LOD scores for linkage anal-
ysis were derived (Lathrop et al. 1985).
During my years at Columbia, other random events
occurred that would greatly influence my career direc-
tion. After my first 2 years, the funding with which I
was brought there unfortunately and unexpectedly dis-
appeared; I was advised to apply for grant money to
support myself and specifically was directed to apply for
a career-development award. At Columbia in those days,
there were no true genetic epidemiologists or statistical
geneticists, so it was entirely unclear who could serve as
a mentor on my grant. One of my colleagues in psy-
chiatry recommended that I contact Zena Stein, an epi-
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demiologist with an interest in birth defects who resided
in the School of Public Health. It was a fortuitous rec-
ommendation. After meeting with Zena, I recognized
that, despite all the extensive training I had had at
UCLA, the one area that was lacking in my background
was epidemiology. This gap, previously unrecognized,
now seemed particularly prominent, given my self-de-
scription as a genetic epidemiologist (i.e., an epidemi-
ologist with no formal training in epidemiology). Zena
generously offered to be my mentor, and both she and
her husband, Mervyn Susser, spent the next 2 years pro-
viding training in epidemiology for me. Again, I was
fortunate to have landed in an outstanding environment
to obtain such tutelage. It didn’t take me long to realize
that epidemiology had much in common with popula-
tion genetics, since both disciplines involve the study of
patterns of disease in populations, with epidemiology
focusing heavily on measurement and environmental
components and population genetics focusing on expla-
nations for observed patterns of gene frequencies. More
than anything else, studying epidemiology broadened
my perspective about the multifactorial nature of disease
causation and the need for a framework to consider host
and exposure factors together.
My recruitment to Yale in 1984 provided me an op-
portunity to flourish, with a joint appointment in the
two departments that most closely reflected my academic
interests—the Department of Epidemiology and Public
Health (Division of Biostatistics) and the Department of
Human Genetics. For the next 10 years, my work re-
flected the developments occurring in molecular biology
and human genetics. The development of short-tandem-
repeat markers, or microsatellites, spanning the genome
(Litt and Luty 1989; Weber and May 1989) greatly fa-
cilitated human linkage analysis, and the era of posi-
tional cloning had come to the fore. Parametric multi-
point linkage analysis was established as an essential tool
for disease-gene mapping. Because my appointment at
Columbia had been in psychiatry and I had worked on
psychiatric disorders—and this remained true also at
Yale—my attention was focused on the role linkage anal-
ysis could play in identifying the genetic contribution to
complex, or non-Mendelian, disease. To that point, the
dogma was that linkage analysis could be employed only
for traits that had been previously subjected to segre-
gation analysis and had shown evidence for a major-
gene contribution and that such genetic contribution
could then be modeled in linkage analysis based on the
results of segregation analysis. However, my experience
with segregation analysis at the time was that results
were often equivocal—sometimes producing no or poor
evidence of a major gene when one exists, other times
producing evidence for a major gene when none exists.
I also had learned from the example of HLA-associated
diseases such as type 1 diabetes that clear linkage evi-
dence could be obtained, even from relatively small sam-
ples of sib pairs, when prior segregation analysis was
equivocal in accurately demonstrating the mode of in-
heritance. In fact, for complex traits, segregation analysis
rarely, if ever, has the power, when based simply on
family trait patterns, to illuminate complex genetic ar-
chitectures. I therefore examined the range of models of
inheritance and the magnitude of genetic effects that
could be detected through linkage analysis, using small
constellations of affected family members, even in the
absence of prior segregation evidence. I also realized that
understanding inheritance of complex diseases would
require the use of genetic markers. It was clear that the
power of linkage analysis depended primarily on the
magnitude of effect of the locus under consideration,
most simply measured by its impact on familial aggre-
gation (for a discrete trait) or by proportion of variance
explained (for a continuous trait). Because the molecular
and statistical approaches for identifying Mendelian
genes were well in hand, the field generally started to
refocus attention on the more common complex diseases
(often characterized as multifactorial), since the public
health impact of these disorders is markedly greater.
Sibship-based linkage studies for common diseases
started to abound, but the success rate did not match
the spectacular history of linkage analysis in the Men-
delian setting.
While at Yale, my collaboration with epidemiologists,
both faculty and students continued. One colleague I
worked with extensively, both in teaching and research,
was Kathleen Merikangas, a psychiatric epidemiologist
with interests in genetics. We spoke frequently about the
state of the field of genetic epidemiology and where it
was and should be going. We continued these discussions
even after my move to Stanford in 1995. We began to
develop an awareness that the linkage approach, al-
though having some modest success in complex diseases,
was unlikely to identify the large majority of genes. We
were influenced by a news item that appeared in Science
on July 14, 1995, entitled “Epidemiology Faces Its Lim-
its.” The article described the difficult state of affairs
experienced by epidemiologists in trying to reliably iden-
tify disease risk factors when the relative risks are not
large. Although the article did not discuss human ge-
netics or genetic epidemiology, we realized that many of
the comments could apply to the developing situation
in human genetics as well.
We wrote a perspective for Science, at first reflecting
the parallel trends occurring in epidemiology and human
genetics. The original title of the article was “Human
Genetics Facing Its Limits.” However, upon reflection,
we realized that the tone of the article was too pessi-
mistic. It was our belief that if we were to publish such
an article, it would not be sufficient simply to point out
the limitations of current approaches; we needed to pro-
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Figure 1 Reproduction of the table by Risch and Merikangas (1996). Used with permission from the publisher.
vide an alternative. The answer, once again, came from
developments in molecular biology—namely, the Hu-
man Genome Project. If we could have any tool to use
for mapping disease genes, we wondered what would it
be? Again, on the basis of my experience with HLA-
associated diseases and my knowledge about disease as-
sociations with other blood-group systems, I knew that
many of these associations, although highly significant
statistically, would not produce substantial or robust
linkage signals. Therefore, why not reverse the process
of positional cloning? Instead of searching randomly
through the genome by location, why not start with
genetic variants and test them directly as candidates?
The problem with candidate-gene association studies
had been the limited number of candidates and, there-
fore, the low prior probability of a “hit.” But what if
we could compile a list of all polymorphisms in the hu-
man genome? The number would certainly be large, but
what impact would that have on power if we needed to
use a very strict level of significance to protect against
false positives? By use of simple power calculations, we
showed that, even with use of an extremely strict level
of significance, the power of association studies would
be dramatically greater to detect genes of modest effect
than would linkage analysis. Indeed, in many cases, the
sample sizes required for linkage would be unrealistically
large. Figure 1 reproduces the table we presented in the
Science perspective that shows the dramatic difference
in required sample size. Therefore, we concluded that
the main impediment to the identification of disease
genes of modest effect was not statistical but the lack of
the appropriate reagent-—namely, a compendium of the
polymorphisms present in the human population. To
provide a more optimistic vision, we changed the title
of the perspective to “The Future of Genetic Studies
of Complex Human Diseases” (Risch and Merikangas
1996).
The writing of this perspective brought me back full
circle to my graduate training. After having spent the
prior 15 years focusing on genetic epidemiology and the
study of disease, I realized fully the implications of what
we were proposing: that it would bring population ge-
netics into greater prominence in human genetics. This
is because genetic association studies require knowledge
of both epidemiological and population-genetic princi-
ples. It is important to know how allele frequencies vary
in the population and how linked variants are associated
with each other (i.e., patterns of linkage disequilibrium).
Equally, it is important to avoid confounding (an epi-
demiological principle) due to nonrandom mating.
It has been 8 years since our perspective was pub-
lished, and 17 million confirmed SNPs (single-nucleotide
polymorphisms) are currently listed in the SNP database
dbSNP. Molecular technology for sequencing multiple
genomes and for identifying and characterizing genetic
variation in the human population has proceeded apace.
Patterns of linkage disequilibrium are being character-
ized and attention being paid to how such patterns—
and genetic structure itself—vary across populations of
differing geographic origin. Large-scale association stud-
ies are being planned. Much has also been written about
different strategies for conducting genomewide associ-
ation studies—namely, a map-based approach based on
patterns of linkage disequilibrium, sometimes referred
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Table 2
Some Fields That Will Contribute to the Future of Complex-Disease Genetics
Field Contribution
Human genetics Correlate genotypes with in vivo phenotypes
Molecular biology Make genotyping and sequencing more efficient and cost-effective
Human evolution and population genetics Understand the distribution of genetic variation in the human population and how
it is structured
Comparative evolution Predict functional elements of the human genome, especially outside coding regions
Functional genomics and cell biology Establish relationships between sequence variation and in vitro phenotypes
Statistics Develop and apply novel methods for analyzing large volumes of SNP data
Epidemiology Develop and maintain large, population-based clinical databases for application
of genomic technology and epidemiological methods; environmental risk factors
Medicine Further refine clinical entities to reduce etiologic heterogeneity
Bioinformatics Develop, maintain, and manipulate large databases storing clinical, genetic, and
epidemiological data
Pharmacogenetics Discover and characterize the role of genetic variation in treatment response and
side effects
to as “the HapMap” (Collins et al. 1997; International
HapMap Consortium 2003)—versus a sequence-based
approach, with focus on the variation occurring in cod-
ing and adjacent regions previously implicated in the vast
majority of positionally cloned Mendelian genes (Risch
2000; Botstein and Risch 2003). Also, optimal epide-
miologic study designs for this endeavor have been ex-
tensively discussed, with focus on nested case-control
studies versus cohort studies (Caporaso et al. 1999;
Langholz et al. 1999; Clayton and McKeigue 2001).
Plans are under way to develop large-scale cohorts or
their equivalent for executing these studies in an epi-
demiologically rigorous and reproducible way.
Although the confluence of human population genet-
ics and epidemiology for the future of human-genetics
studies appears on the horizon, it is clear that many
disciplines must contribute to this effort if we are to be
successful on a large scale; some of these disciplines have
been listed in table 2. Identification of functional ele-
ments in the human genome and their relevance for hu-
man traits and disease will require a concerted effort
among scientists from a broad array of disciplines.
In summary, I must also recognize the many people
who have contributed to and influenced my career and
development—my many teachers, students, and col-
leagues. I am deeply indebted to my graduate-school
advisers and mentors, Ken Lange and Anne Spence, for
introducing me to the fields of human genetics and sta-
tistical genetics; Ayesha Gill, for teaching me population
genetics; and all three, for their support and guidance
through graduate school. I am also grateful to Zena Stein
and Mervyn Susser for the excellent postgraduate su-
pervision and training they provided me in epidemiology.
I must also acknowledge my lifelong mentors, my par-
ents, Frank and Sonya Risch, who were constant and
uncompromising in the support and love they showed
me in all of my academic endeavors.
Finally, I would I also like to comment about the man
for whom this award is named, Curt Stern. Much has
been said by previous recipients of this award about
Stern’s seminal research contributions to genetics. I
would like to focus on another aspect of his career; that
is, the positive impact he had in mentoring his trainees.
It has been noted by many who had the good fortune
to sit in on his classes at UC Berkeley that Stern was a
gifted teacher, and many have also written about how
generous and supportive Stern was as a mentor and ad-
viser. I would like to reflect on one story that has par-
ticular meaning for me, an anecdote reported by one of
his former advisees, the great human geneticist James
Neel. After the publication of the Science perspective I
wrote with Kathleen Merikangas (Risch and Merikangas
1996), a number of colleagues contacted us to say that
the numbers in the table (see fig. 1) did not conform to
the formulas given in the paper. Re-examination revealed
to me that I had created an error in translating the for-
mulas into the computer program I had used to generate
the number of families required for linkage analysis, with
the effect that the numbers given in the table were too
small by a factor of ∼2. Apparently, during his graduate
career, Neel had also made some embarrassing error and
had to confront his adviser, Curt Stern, about it. The
following is Neel’s description of the incident (Neel
1983):
During my first year of graduate work with Stern
I did some incredibly stupid thing. I do not remember
what it was, but it would be impossible to forget how
Stern handled it. Having straightened me out, he
paused a minute. I was waiting for the next blow to
fall when he smiled and said, “Jim,…great men make
great mistakes.”
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